Almac Diagnostics Expands Biomarker Discovery Service with XCel Array
June 08, 2010
Almac Diagnostics Expands Biomarker Discovery Service with XCel Array
The new chip, based on Affymetrix's GeneChip platform, is intended for use in studies where cross-disease compatibility is important, an attribute that Almac calls a "notable advantage" for its pharmaceutical customers.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.